Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626119 · ClinicalTrials.gov registry record
Vibro-Acoustography Imaging in Finding Breast Microcalcifications and Lesions in Women
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 34
- Enrollment target
NCT00626119: Completed study, sponsored by Mayo Clinic.
NCT00626119 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00626119 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
RATIONALE: New diagnostic procedures, such as vibro-acoustography imaging, may be an effective method of finding microcalcifications and lesions in the breast. PURPOSE: This clinical trial is studying how well vibro-acoustography imaging works in finding breast microcalcifications and lesions in women.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2001-06 |
| Est. Completion | 2012-02 |
What the finished NCT00626119 record still lists
NCT00626119 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00626119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00626119 about?
NCT00626119 is a clinical study titled "Vibro-Acoustography Imaging in Finding Breast Microcalcifications and Lesions in Women". RATIONALE: New diagnostic procedures, such as vibro-acoustography imaging, may be an effective method of finding microcalcifications and lesions in the breast. PURPOSE: This clinical trial is studying how well vibro-acoustography imaging works in finding breast microcalcifications and lesions in wo...
What is the current status of trial NCT00626119?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2001-06. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT00626119?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia